Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
Beacon
®
Optofluidic System
Beacon Select™ Optofluidic System
The Lightning
®
Optofluidic System
Culture Station™ System
Technology
Company
TechAccess Subscriptions
Innovation Centers
News & Articles
Press Releases
Events
Company
Investor Relations
Careers
Customer Spotlights
Publications
Careers
Resources
Support
Get In Touch
Latest
Blog
Blog
07.15.21
Confident clonality: How to make your IND approval a reality
Blog
07.15.21
Multi-omic profiling of T cells
Blog
07.15.21
Show Me How: Recovering lead molecules, not just sequences
Blog
07.15.21
Ask Me Anything: In the field and overseas
Blog
05.25.21
COVID-19: In it for the Long Haul
Blog
05.22.21
What is the Biodiversity We Don’t Think About
Blog
04.12.21
U.S. military researchers turn to the Berkeley Lights Platform in the fight against pandemics
Blog
04.07.21
Show Me How: Deciphering natural killer cells
Blog
03.02.21
Ask Me Anything: A world of change
Blog
02.23.21
Racing to find the right cells: Our COVID-19 success stories
Blog
02.19.21
Cell Therapy Development and Improving Patient Access
Blog
11.27.20
AstraZeneca enters Phase III clinical trials using antibodies found on the Berkeley Lights Beacon
®
system
Blog
06.25.20
Collision from Home Panel Recap: Berkeley Lights CEO Dr. Eric Hobbs Talks COVID-19 Antibody Discovery
Blog
04.20.20
Speeding the COVID-19 Drug Development Process
Blog
04.13.20
COVID-19 Fact or Fiction
Blog
04.01.20
Everything You Need to Know About Coronavirus
Blog
03.25.20
Shortening Long Drug and Vaccine Development Timelines: Beating Coronavirus with Antibody Discovery